Oxidation of tow density tipoprotein by mesangial cells may promote gtomerular injury. Low density lipoprotein (LDL) deposition and local oxidation play a key role in the pathogenesis of atherosclerosis and may likewise contribute to glomerular injury. These studies were designed to determine whether cultured human mesangial cells oxidize homologous LDL and to compare the effects of unmodified and oxidized lipoprotein on cell proliferation, viability and eicosanoid production. Cell-mediated lipoprotein oxidation was demonstrated and could be suppressed by oxygen free radical scavengers and inhibitors of arachidonic acid metabolism. When incubated with cells, oxidized LDL (Ox-LDL) at concentrations up to and including 100 .tg/ml reduced 3H-thymidine incorporation without causing cytotoxicity as assessed by lactate dehydrogenase release. Under the same conditions there was a concentration-dependent increase in the synthesis of prostaglandins E2, 6-keto-PGF1, and thromboxane B2. In contrast, unmodified LDL enhanced DNA synthesis at concentrations less than 40 g/ml and had little effect on eicosanoid production. These results demonstrate that exogenous oxidized LDL inhibits mesangial cell proliferation and increases eicosanoid synthesis. Unmodified lipoprotein can be directly oxidized by these cells through mechanisms that involve generation of oxygen free radicals.
Oxidation of tow density tipoprotein by mesangial cells may promote gtomerular injury. Low density lipoprotein (LDL) deposition and local oxidation play a key role in the pathogenesis of atherosclerosis and may likewise contribute to glomerular injury. These studies were designed to determine whether cultured human mesangial cells oxidize homologous LDL and to compare the effects of unmodified and oxidized lipoprotein on cell proliferation, viability and eicosanoid production. Cell-mediated lipoprotein oxidation was demonstrated and could be suppressed by oxygen free radical scavengers and inhibitors of arachidonic acid metabolism. When incubated with cells, oxidized LDL (Ox-LDL) at concentrations up to and including 100 .tg/ml reduced 3H-thymidine incorporation without causing cytotoxicity as assessed by lactate dehydrogenase release. Under the same conditions there was a concentration-dependent increase in the synthesis of prostaglandins E2, 6-keto-PGF1, and thromboxane B2. In contrast, unmodified LDL enhanced DNA synthesis at concentrations less than 40 g/ml and had little effect on eicosanoid production. These results demonstrate that exogenous oxidized LDL inhibits mesangial cell proliferation and increases eicosanoid synthesis. Unmodified lipoprotein can be directly oxidized by these cells through mechanisms that involve generation of oxygen free radicals.
Recent animal studies have suggested that lipids contribute to renal injury and that correction of hyperlipidemia may slow the progression of chronic renal failure [1, 2] . Histological analysis of scarred glomeruli has revealed several features in common with atherosclerotic lesions suggesting that both glomeruloscierosis and atherosclerosis may share common pathogenic mechanisms [3] . This analogy is further strengthened by in vitro studies demonstrating morphological and functional similarities between vascular smooth muscle and glomerular mesangial cells, both of which play a key role in these scarring processes [4] .
Accumulation of low density lipoprotein (LDL) has long been recognized as an early event in the development of atherosclerotic plaques [5] . LDL particles deposited in the arterial wall appear to undergo local oxidation [6] , a process that may be mediated by endothelial cells, vascular smooth muscle cells and macrophages [7, 8] . Oxidation of LDL could enhance the In animal models of renal disease, lipid deposition and mononuclear cell infiltration are recognized early features of glomeruloscierosis and are exacerbated by high cholesterol diets which promote glomerular injury [11, 12] . Analysis of renal tissue from these animals has indicated that lipid accumulation is particularly prominent in visceral epithelial cells and in the mesangium where foam cells are frequently identified [11, 12] . Lipid deposits contain apoproteins usually associated with very low density lipoprotein (VLDL) and LDL particles [13] . In addition, Ox-LDL has been identified in the glomeruli of cholesterol-fed nephrotic rats using specific monoclonal antibodies [14] . Based on our understanding of the pathogenic mechanisms involved in atherogenesis it has been proposed that oxidative modification of LDL may contribute to glornerular injury [1] . Thus Ox-LDL could promote a chronic inflammatory reaction within the glomerulus, might directly injure glomerular cells and might modify secretion of vasoactive mediators and matrix components. Although there is no direct evidence to support this hypothesis, in vivo studies have suggested that LDL oxidation contributes to enhanced thromboxane production and to renal vasoconstriction in cholesterol-fed animals [1, 15] .
Previous in Vitro studies of glomerular cell-lipoprotein interactions have demonstrated that mesangial cells show a biphasic proliferative response when increasing amounts of LDL are added to the incubation medium. Growth inhibition was observed at higher lipoprotein concentrations which were cytotoxic to proliferating cells [16] [17] [18] . However, all but one of these studies were based on a heterologous system in which rat cells were exposed to human LDL and did not distinguish between the effects of unmodified and oxidized lipoprotein. When LDL was chemically oxidized and added to cultured rat mesangial cells a cytotoxic effect could be demonstrated [19] .
The following experiments were designed to determine whether human mesangial cells oxidize homologous LDL and if so, to investigate the possible metabolic pathways involved in this process. In addition, since oxidation of LDL might influence its interactions with mesangial cells, the effects of unmodified and subcytotoxic concentrations of oxidized lipoprotein on cell proliferation, viability and eicosanoid synthesis were cornpared.
Methods
Glomerular cell culture and characterization Human renal tissue was obtained from macroscopically normal areas of nephrectomy specimens containing well circumscribed renal tumors or from cadaver kidneys unsuitable for transplantation. Glomeruli were separated by differential sieving of cortical material, collagenase digested and plated. Incubation medium comprised RPM! supplemented with 20% heatinactivated fetal calf serum, glutamine (300 jsglml), insulin (5 p.glml) transferrin (5 gIml) and selenium (5 nglml). Dishes were incubated at 37°C in a humidified atmosphere of 5% CO2 and 95% air. Stellate-shaped mesangial cells which predominated after six to eight days were passaged and outgrew other cells types in prolonged culture. Epithelial cells were obtained by trypsinizing early outgrowths and passing suspended cells through a 90 pm sieve to remove whole glomeruli. These cells were maintained in medium with a lower serum concentration (10%) further supplemented with 0.4 sg/ml hydrocortisone. The characterization of these two cell types has been described in detail in earlier publications [20, 21] . Cells from passages 2 to 9 were plated in 2.0 cm2 microwells (Falcon Scientific Supplies, London, UK) and grown to confluence. After certain experiments cells were dissolved in 0.1 N NaOH and the cell protein content of individual wells estimated using the method of Bradford [221. Isolation and oxidation of LDL Plasma was collected from normal human volunteers into a preservative cocktail to prevent oxidation and proteolytic degradation [23] . LDL (density range 1.019 to 1.063 g/ml) was isolated by sequential ultracentrifugation (Centrikon Tl065 ultracentrifuge with TFT 50.38 rotor) at 37,000 rpm for 20 hours at 4°C using potassium bromide (KBr) for density adjustment.
The isolated lipoprotein was dialyzed against 0.15 M NaCl containing 0.3 m ethylene diaminetetraacetic acid EDTA (pH 7.4) to remove KBr and subsequently against sodium carboxymethylcellulose (Aquacide II, Calbiochem Novabiochem UK Ltd, Nottingham, UK) to concentrate. Samples were passed through a 0.22 m filter (Millipore UK, Harrow, UK) to sterilize and stored under nitrogen at 4°C. The purity of isolated lipoproteins was assessed by chemical analysis and by determination of the apoprotein composition using sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The protein, triglyceride, cholesterol and phospholipid composition of isolated LDL was in agreement with published data [24] .
SDS-PAGE demonstrated a single apoprotein (apo B 100) band suggesting minimal contamination with other lipoprotein particles.
LDL was oxidized in a cell-free system by incubation with copper ions. Lipoprotein (200 jsglml) was suspended in 0.15 M NaC1 (pH 7.4) and freshly prepared CuSO4 added to a final concentration of 5 to 10 M. Following incubation for 24 hours at 37°C, 25 M EDTA was added to prevent further oxidation. Modified LDL was recovered by ultracentrifugation at a density of 1.100 glml then dialyzed and concentrated as described above. Native and oxidized lipoproteins were quantified by measuring protein concentration using the Lowry method [25] . Oxidation of LDL was confirmed by measuring mobility on agarose gel and by analysis of the thiobarbituric acid reactive substance (TBARS) content of samples. To assess TBARS, LDL (30 to 50 gIml) suspended in 0.9% saline was mixed with 20% trichloroacetic acid and 0.67% thiobarbituric acid. Samples were heated to 96°C for 60 minutes, cooled, centrifuged at 1500 g for 10 minutes and the absorbence of the supernatant measured at a wavelength of 532 nm [26] . Alternatively, samples were shaken vigorously with n-butanol, centrifuged at 1500 g for 10 minutes and the organic phase assayed fluorometrically using excitation and emission wavelengths of 515 nm and 553 nm, respectively. Freshly diluted 1,1,3,3-tetrarnethoxypropane, which yields malondialdehyde (MDA) when exposed to thiobarbituric acid, was used as a standard and results were expressed as MDA equivalents per mg LDL protein. The TBARS content of LDL oxidized by incubation with copper ions was consistently greater than 10 nM MDAImg protein compared with less than 3 nM MDA/mg for unmodified lipoprotein immediately after isolation. On agarose gel electrophoresis, oxidized LDL was shown to have greater cationic charge than unmodified lipoprotein (Fig. 1) . To check the stability of stored unmodified LDL, samples were analyzed for evidence of oxidation at regular intervals. Even eight weeks after isolation, no increase in TBARS content or change in electrophoretic mobility could be detected.
Mod/1cation of LDL by cells LDL (200 tg/ml) was added to microwells containing confluent cells incubated in RPM! or to control wells containing medium but no cells. After 24 hours, 25 sM EDTA was added to prevent further oxidation and the media centrifuged at 1000 g for 15 minutes at 4°C to remove detached cells. LDL oxidation was determined by measuring TBARS content as described above. Cell-specific oxidation was taken to be the difference in TBARS values of recovered LDL incubated in wells with cells and in wells without cells under otherwise identical experimental conditions. The mechanisms of cell-specific LDL oxidation were investigated by addition of antioxidants including mannitol (1.25 to 5 mM), butylated hydroxytoluene (BHT, ito 25 sM) superoxide dismutase (0.2 to 0.6 mg/ml), catalase (50 to 200 U/mI), /3-carotene (10 to 25 ILM), a cyclooxygenase inhibitor (indornethacin, 10 to 25 sM) a lipoxygenase and monooxygenase inhibitor (nordihydroguaiaretic acid, NDGA, I to 10 jzM) and a competitive inhibitor of lipoxygenase, cyclooxygenase and monooxygenase pathways of arachidonic acid metabolism (eicosatetraynoic acid, ETYA, 10 to 25 sM).
Proliferation and cytotoxicity studies Incubation media containing human LDL and Ox-LDL at a range of different concentrations were prepared for these studies. Growth medium was rendered effectively lipid-free by ultracentrifugation of FCS at 37,000 rpm for 24 hours at 4°C using KBr at a density of 1.250 g/ml. Serum was then dialysed extensively against buffer (see above) and sterilized by filtration through a 0.22 tm filter (Millipore UK), This modified FCS was used in place of normal FCS to make lipoprotein-free incubation medium to which human LDL or Ox-LDL were added at concentrations between 10 and 100 gIml. The TBARS content of chemically oxidized LDL used for these experiments was 10 to 15 flM MDA/mg protein.
The rate of cell proliferation in the above lipoprotein-supplemented media was estimated by measuring incorporation of 3H-thymidine. After 48 hours preincubation in serum-free medium, cells were grown in experimental media containing LDL or Ox-LDL and 3H-thymidine (37 KBq/ml). Incorporation was halted after 24 hours by washing cells six times with ice-cold phosphate-buffered saline (PBS), and the cell layer was dissolved by addition of 0.5 N NaOH. Aliqouts of cell suspension were counted for 3H activity in a p liquid scintillation counter.
Uptake of thymidine by cells grown in lipoprotein-supplemented media was expressed as a percentage of incorporation by control cells grown in regular medium under identical experimental conditions. Cytotoxicity was assessed by measuring lactate dehydrogenase (LDH) released into cell-conditioned medium. Enzyme concentrations were determined from the rate of oxidation of nicotine adenine dinucleotide (measured as a change in optical density) during LDH-catalyzed conversion of pyruvate to lactate as previously described [27] . Briefly, triplicate 150 l Cells growth-arrested in serum-free conditions for 48 hours were incubated with 10 to 100 g/ml unmodified or chemically oxidized LDL (TBARS content 10 to 15 flM MDA/mg protein) for 24 hours at 37°C. Concentrations of PGE2 and of the stable metabolites of PG!2 (6-keto-PGF1a) and thromboxane (TX) A2 (TXB2) in cell-conditioned media were measured by radioimmunoassay using highly specific rabbit antibodies (Bioclinical Services Ltd, Cardiff, UK). A 100 sl sample of medium was mixed with anti-eicosanoid antibody, a known amount of radiolabeled eicosanoid (Amersham International plc, Amersham, UK) and a second goat anti-rabbit y-globulin antibody (Calbiochem Novabiochem UK Ltd) in buffer and incubated overnight at 4°C. Bound and unbound ligands were separated by centrifugation at 10,000 g for 30 minutes, the resulting pellet was redissolved in 0.1 N NaOH, added to scintillation fluid and counted in a /3 liquid scintillation counter. The unknown concentration of eicosanoid was calculated using standards included in each assay. Cell protein content of each well was estimated using the Bradford method and eicosanoid concentrations expressed as nglmg cell protein.
Statistical Analysis
Results are expressed as mean 1 standard deviation unless otherwise indicated. Statistical analysis was performed using a paired Students t-test or where stated by analysis of variance (ANOVA).
Results
Lipoprotein oxidation by glomerular cells Incubation of LDL in RPM! led to oxidation of particles even in control wells which did not contain cells. After 24 hours at 37°C, the TBARS content of lipoprotein increased from <3 to 6.7 1.0 flM MDA/mg LDL protein, and there was a corresponding change in electrophoretic mobility on agarose gel. In wells containing mesangial cells, lipoprotein oxidation was further enhanced as demonstrated by a higher TBARS value (19.7 0.4 nM MDAImg LDL protein, P < 0.001 vs. control wells; Fig. 2 ) and by a greater increase in electrophoretic mobility (Fig. 3) . Cell-specific oxidation (13.0 nt MDAImg cell protein) thus accounted for 66.0% of the total TBARS content of modified lipoprotein under these conditions. In contrast to mesangial cells, glomerular epithelial cells did not oxidize LDL (Fig. 2) .
Inhibition of oxidation
The addition of a number of antioxidants inhibited cellmediated modification of lipoprotein particles (Fig. 4) . Although some of these compounds were effective over a range of different concentrations, those concentrations that had the greatest inhibitory effect are quoted below. Compared to no Origin -. inhibitor (100%), mannitol (a hydroxyl radical scavenger) almost completely protected LDL, reducing cell specific oxidation to a mean (SD) of9.2% (8.8%) when added at a concentration of 5 mM (P < 0.01). Addition of 25 tM BHT (a non-specific free oxygen radical scavenger) reduced cell-mediated LDL oxidation to 20.8% (1.5%; P < 0.001) and superoxide dismutase to 53.1% (3.0%; P < 0.01). Catalase tended to inhibit LDL oxidation although this result did not reach statistical significance, while /3-carotene (an endogenous carotenoid that binds singlet oxygen species) was ineffective. These results suggest that the generation of oxygen free radicals by mesangial cells might contribute to oxidation. To determine whether arachidonic acid metabolism was a source of these molecules, a variety of enzyme inhibitors were added to the incubation medium. The lipoxygenase and monooxygenase inhibitor NDGA reduced LDL modification by cells in a concentrationdependent fashion. At 5.0 /.LM this inhibitor decreased cellspecific oxidation to 1.8% (2.2%) of control (P < 0.001) and at higher concentrations completely inhibited the ability of cells to modify LDL. Inhibition of cyclooxygenase by indomethacin (10 ,tLM) reduced cell-mediated oxidation of LDL to 63.6% (0.9%; P < 0.01) and addition of the arachidonic acid analogue ETYA (25 jsM) to 39.9% (6.3%; P < 0.01). Taken together these findings indicate that the metabolism of arachidonic acid provides a source of oxygen radicals for cell-mediated LDL oxidation.
Cell proliferation, viability and cytotoxicity In four separate experiments, human mesangial cells showed a biphasic proliferative response when an increasing concentra- tion of unmodified human LDL was added to lipoproteindepleted incubation medium. Compared to control conditions (no LDL), 3H-thymidine uptake was significantly enhanced at 20 pg/m1 LDL but was no different at higher concentrations (Fig. 5) . In contrast, at 20 pg/ml and above, Ox-LDL significantly inhibited thymidine incorporation. While the addition of 20 g/ml of unmodified LDL increased mean (SD) 3H-thymidine uptake to 116% (7.5%) compared to control conditions (100%, P <0.05), Ox-LDL significantly inhibited incorporation to 93.5% (3.9%) at an equivalent concentration (P < 0.05). At 100 jsg/ml Ox-LDL suppressed thymidine uptake to 49.0% (20.0%; P < 0.05 vs. no LDL) but unmodified lipoprotein to only 75.3% (13.9%) of control (P NS). Taking all concentrations into account, oxidized LDL significantly reduced nucleic acid incorporation when compared to unmodified lipoprotein (P <0.05, ANOVA). Measurement of LDH release confirmed that at concentrations up to and including 100 pgIml, neither LDL or Ox-LDL caused toxicity (Fig. 5) . In the same four experiments, cytotoxicity was only observed at Ox-LDL concentrations greater than 100 jg!ml. Cells exposed to 200 jsg/ml of unmodified or oxidized LDL released 17.1% (15.4%) and 43.9% (13.4%) of total intracellular LDH respectively (P < 0.05).
Eicosanoid production Cells preincubated in serum-free conditions for 48 hours did not synthesize measurable concentrations of eicosanoids when ified LDL caused only a small non-significant increase in production of POE2, 6-keto-PGF1 and TXB2 (Fig. 6) . In contrast, a marked concentration-dependent increase in the production of all three eicosanoids was demonstrated when chemically oxidized LDL was added to the incubation medium.
This effect was apparent even at concentrations as low as 40 jsg/ml. Cells exposed to 100 g/ml of Ox-LDL synthesized 210 45 .0 ng/mg PGE2, 1060.0 235.0 ng/mg 6-keto-PGF1, and 46.4 15.8 ng/mg TXB2 compared with 9.9 2.8, 173.7 60.0 and 2. 1 1.7 ng/mg, respectively, at an equivalent concentration of unmodified lipoprotein. The effects of unmodified and Ox-LDL on prostaglandin and thromboxane production were significantly different in the case of all three eicosanoids when analyzed by ANOVA.
Having established that chemically oxidized LDL stimulated eicosanoid production we repeated these experiments with lipoprotein that had been oxidized by mesangial cells. LDL exposed to mesangial cells for 24 hours was recovered from conditioned medium by ultracentrifugation, added to cells growth-arrested in microwells and incubated for a further 24 hours at 37°C. LDL incubated in microwells with medium but without cells served as a control. In two similar experiments, this cell-modified LDL stimulated mesangial cell PGE2 production in a concentration-dependent manner as had been previously observed with chemically modified lipoprotein (Fig. 7) . LDL that had been incubated in medium without cells caused a small but less marked increase in POE2 synthesis consistent with the small increase in TBARS content and electrophoretic mobility demonstrated in previous experiments. studies, but may be related to quantitative differences in the ability of these two cell types to produce reactive oxygen metabolites. In a separate study, LDL has been shown to stimulate production of superoxide anions by human mesangial cells (S. Jones, personal communication), thus confirming previously published results [28] . In contrast, the ability of glomerular epithelial cells to synthesize these highly reactive molecules is less well established [29] .
The mechanisms by which cultured vascular endothelial cells, smooth muscle cells and macrophages oxidize LDL in vitro have been investigated in detail. The involvement of reactive oxygen metabolites is demonstrated by the fact that both SOD and BHT effectively inhibit cell-mediated LDL oxidation [30] . Although a variety of intracellular reactions may provide a source of reactive oxygen species for LDL oxidation, the lipoxygenase pathway which generates superoxide anions during conversion of arachidonic acid to lipid hydroperoxides [48] with permission) appears to be particularly important in this respect. This is demonstrated by the fact that cell-induced lipoprotein modification can be mimicked in a cell-free system by incubating LDL with lipoxygenase enzyme extracted from soybeans [31] . Using lipoxygenase inhibitors it has been possible to demonstrate that this pathway is the predominant mechanism responsible for LDL oxidation by endothelial cells and macrophages [32, 33] . In addition, lipoxygenase mRNA and protein have been identified in association with Ox-LDL in macrophage-rich areas of atherosclerotic lesions, suggesting that this enzyme may play an important role in LDL oxidation in vivo [34] . Our studies demonstrating that oxidation of LDL by mesangial cells was inhibited by mannitol, superoxide dismutase and BHT suggest that reactive oxygen metabolites are also involved in this process. Although catalase tended to inhibit oxidation, this result was not statistically significant when compared to control. To determine whether arachidonic acid metabolism was an important source of reactive oxygen species, various inhibitors were added during incubation studies. Of these compounds NDGA (a lipoxygenase and monooxygenase inhibitor) was the most effective, completely abolishing cell-specific LDL oxidation at concentrations greater than 5 M. In addition, ETYA, an analogue that blocks all three major pathways of arachidonic acid metabolism also inhibited oxidation as did indomethacin. Although both NDGA and ETYA have anti-oxidant effects which are independent of their ability to block eicosanoid synthesis, these results suggest that arachidonic acid metabolism, and more specifically the lipoxygenase and cytochrome P-450 pathways, contribute to LDL oxidation by mesangial cells. Since cells were studied in the quiescent state and a non-proliferative concentration of LDL was used, it would appear that cell-mediated oxidation is independent of proliferation. Our findings are broadly consistent with those of previously reported experiments based on guinea pig mesangial cells and a recent study that utilized human cells [18, 35] .
Just as oxidation of LDL particles enhances their atherogenicity, modification of lipoprotein deposited in the mesangium may promote glomerular injury. Chemical changes to LDL may reduce binding to apo B/E receptors but promote uncontrolled lipoprotein uptake via scavenger receptors [36, 37] . Rat mesangial cells have been shown to possess both types of receptor but preferentially bind and internalize oxidized LDL in vitro [19, [38] [39] [40] . Studies in human mesangial cells have so far identified apo BIE but not scavenger receptors, so it is not clear whether lipoprotein oxidation would enhance LDL uptake [41] . Such changes in receptor recognition would, however, promote lipid accumulation in macrophages which frequently invade the glomerular mesangium in the early stages of glomerular injury [11] . Oxidation of LDL might promote this chronic inflammatory process by up-regulating expression of adhesion molecules and enhancing synthesis of chemotactic substances. LDL has been shown to increase production of monocyte chemoattractant protein-i by human mesangial cells in culture, although the effects of oxidized lipoprotein have not been reported. This cytokine could play a key role in the recruitment of mononuclear cells into the mesangium [28] .
Oxidation also modifies the effects of LDL on cell growth and viability. While unmodified LDL may stimulate cellular proliferation in vitro, oxidized lipoprotein is cytotoxic to a number of different cell types including endothelial cells, vascular smooth muscle cells and fibroblasts [9, 42] . Cells appear to be most susceptible to injury by oxidized lipoprotein during DNA synthesis (the S phase of the cell cycle) [42] . In keeping with earlier studies based on rat tissue culture, our results demonstrate enhanced thymidine incorporation by mesangial cells when low concentrations of unmodified LDL (less than 50 jsglml) are added to the incubation medium [16, 17] . At higher concentrations this lipoprotein tended to inhibit cell proliferation, possibly because auto-oxidation by the cells themselves led to the appearance of Ox-LDL in the medium. A similar biphasic response to increasing LDL concentration was noted in a recent study which utilized human mesangial cells, although proliferation was noted over a wider range of lipoprotein concentrations [18] . In the present study Ox-LDL inhibited cell division at concentrations less than 100 sg/ml but did not cause detectable cell damage. However in contrast to unmodified lipoprotein, higher concentrations of Ox-LDL enhanced LDH release thus indicating cytotoxicity. These results are in keeping with studies in which rat mesangial cells were injured by human Ox-LDL added to the incubation medium [19] . A clear distinction between the growth inhibitory and cytotoxic effects of Ox-LDL has been noted by other investigators in fibroblast cultures [42] . In addition, when the lipid components of Ox-LDL have been separated by thin layer chromatography and added individually to cultured rat mesangial cells, lysophosphatidylcholine has been identified as the major cytotoxic component, although other fractions inhibited growth without causing cell lysis [43] . Thus, local oxidation of LDL in the mesangium could contribute to glomerular injury as a direct result of growth inhibitory or cytotoxic effects.
Lipoproteins may also contribute to glomerular injury by modifying eicosanoid production. In this respect, LDL oxidation has been implicated as a mediator of renal vasoconstriction associated with hypercholesterolemia in rats. In a recent study the antioxidant drug, probucol, corrected the hemodynamic abnormalities usually associated with a high cholesterol diet [15] . Since this drug did not significantly reduce total plasma or LDL cholesterol concentrations and since infusions of a thromboxane receptor antagonist had a similar effect, the authors concluded that LDL oxidation in vivo initiates thromboxanemediated renal vasoconstriction. Studies in non-glomerular cells have confirmed that lipoproteins may modulate production of arachidonic acid metabolites in vitro. For example, uptake of Ox-LDL by macrophages stimulates synthesis of PGE2, PGI2 and leukotriene C4 (LTC) while unmodified LDL has no effect [10] . In smooth muscle cell cultures, unmodified lipoprotein which had not been protected from oxidation stimulated production of PGE2 and PGI2, although this effect was small when compared to that of HDL added to the medium at comparable lipoprotein particles and cell membrane fatty acids it was possible to demonstrate that both LDL and HDL provided arachidonic acid to a phospholipase-sensitive intracellular pool.
We were thus interested to study the effects of LDL and
Ox-LDL on human mesangial cell eicosanoid production. While unmodified lipoprotein had little effect, sub-cytotoxic concentrations of Ox-LDL caused a marked increase in PGE2, PGI2 and TXA2 production. Since LDL auto-oxidized by mesangial cells appeared to have the same effect as chemically oxidized particles, it is conceivable that modification of lipoprotein within the mesangium might increase eicosanoid production by the surrounding cells. In separate studies by other investigators, similar changes in PGE2 production by rat mesangial cells have been demonstrated when unmodified and chemically oxidized LDL were added to culture medium [39, 40] . None of these studies have specifically examined why Ox-LDL should promote eicosanoid synthesis. If human mesangial cells do not possess receptors for Ox-LDL it seems unlikely that these differences in eicosanoid production reflect delivery of arachidonic acid substrate to the cell, particularly since the oxidation process damages polyunsaturated fatty acids within the LDL particle [45] . Alternatively, lipid peroxidation of cell membranes induced by exposure to Ox-LDL may activate phospholipase A2, thereby increasing arachidonic acid release from the cell membrane. Although this process may help to protect cells against oxidant injury by selectively removing peroxidized fatty acids from membrane phospholipids, intact fatty acids may also be hydrolyzed thus providing substrate for eicosanoid synthesis [46] . Regardless of the mechanisms by which Ox-LDL modifies cellular eicosanoid production, such changes in lipid mediators may contribute to lipoprotein-induced glomerular injury [47] . Although it is possible that the effects of increased thromboxane B2 production may be offset by those of prostaglandin E2 or 12 we did not specifically address whether these eicosanoids have opposing effects on cell proliferation or cytotoxic injury.
The results of these studies thus strengthen the analogy between glomeruloscierosis and atherosclerosis. We propose that in the early stages of glomerular injury, LDL is deposited in the glomerulus where it becomes locally oxidized by the action of mesangial cells. The presence of Ox-LDL promotes infiltration of macrophages, modifies the growth and viability of glomerular cells and alters secretion of eicosanoids or other vasoactive mediators [48] . It follows that in addition to lipidlowering drugs, antioxidants may be of value in preserving renal function in the setting of chronic renal failure.
